Will A/C Diagnostics break from Axis to sell its own test?
This article was originally published in Clinica
The Axis-Shield deal was a very public coming together of two small companies. Both of them had competing technologies for homocysteine measurement. Their alternative to merger was five years of patent litigation. However, there was another deal with a homocysteine assay company struck around the same time, which attracted little publicity from Axis.